hVIVO PLC OPORF
Trading Information
- Previous Close Price
- $0.09
- Day Range
- $0.11–0.11
- 52-Week Range
- $0.09–0.11
- Bid/Ask
- $0.00 / $417,200.16
- Shares Outstanding
- 688.40M
- Market Cap
- $74.57M
- Volume/Avg
- 30,504 / 30,504
Key Statistics
- Price/Earnings (Normalized)
- 8.71
- Price/Sales
- 1.22
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
hVIVO PLC is a full-service early phase Contract Research Organisation (CRO). It delivers end-to-end clinical development services to a diverse and expanding client base. The group specialises in conducting human challenge trials across multiple infectious and respiratory indications. It also offers comprehensive virology and immunology laboratory services under the hLAB brand. Through its subsidiary, it provides early-phase clinical trial services and Early Drug Development Consulting and Biometry services to the biopharma sector. It provides development solutions from preclinical stages through Phase II trials, via FluCamp. Geographically, the company generates maximum revenue from Europe, followed by North America, the United Kingdom, and Asia.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 376
- Website
- https://www.hvivo.com
Valuation
|
Metric
|
OPORF
|
|---|---|
Price/Earnings (Normalized) | 8.71 |
Price/Book Value | 1.47 |
Price/Sales | 1.22 |
Price/Cash Flow | 122.36 |
Price/Earnings
OPORF
Financial Strength
|
Metric
|
OPORF
|
|---|---|
Quick Ratio | 1.12 |
Current Ratio | 1.21 |
Interest Coverage | −7.00 |
Quick Ratio
OPORF
Profitability
|
Metric
|
OPORF
|
|---|---|
Return on Assets (Normalized) | −13.60% |
Return on Equity (Normalized) | −27.53% |
Return on Invested Capital (Normalized) | −18.42% |
Return on Assets
OPORF
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|bP>ww&sS | LOCK|^# | $250B | |||
| Danaher Corp
DHR
| LOCK|bvL>hH<@ | LOCK|RV$ | $162B | |||
| Agilent Technologies Inc
A
| LOCK|Lm@q$^n | LOCK|W^! | $49B | |||
| IQVIA Holdings Inc
IQV
| LOCK|MWGFH& | LOCK|JY%L> | $46B | |||
| Waters Corp
WAT
| LOCK|&TwDW<S | LOCK|Dm | $45B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|j?cRP^^ | LOCK|B@$ | $45B | |||
| Illumina Inc
ILMN
| LOCK|sx##^wQ | LOCK|vnGM | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|T$Nfg!V< | LOCK|^KdsK | $34B | |||
| Quest Diagnostics Inc
DGX
| LOCK|k#Zxf>> | LOCK|b^s< | $27B | |||
| Labcorp Holdings Inc
LH
| LOCK|HG#?dj@ | LOCK|f&%FR | $27B |
United States